Form 4: BridgeBio Pharma Director McCormick Acquires Shares and Options
SEC Form 4 Filing
Director Frank McCormick reports acquisition of shares and stock options in BridgeBio Pharma, Inc.
Summary
- Frank McCormick, a director of BridgeBio Pharma, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 21, 2024, McCormick acquired 26,014 shares via stock options with an exercise price of $27.36.
- These options vest in equal tranches annually, with full vesting by June 21, 2027, contingent on continued service as a director.
- McCormick directly owns 120,086 shares of common stock.
- McCormick indirectly owns 979,979 shares through The Francis P. McCormick Rev Trust U/A DTD 1/27/2017.
- 352,290 shares were transferred from direct ownership to the trust account on April 16, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options by a director could be seen as a positive signal, but it's not overwhelmingly so.
Positives
- Director's acquisition of shares and options may signal confidence in the company's future prospects.
Future Outlook
The stock options vest over three years, contingent on the director's continued service.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the buying and selling activity of company insiders.
Stakeholder Impact
- Shareholders can use this information to assess the confidence of a key insider in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 1/27/2017 | Date of The Francis P. McCormick Rev Trust U/A |
| 04/16/2024 | Date of transfer of 352,290 shares to trust account |
| 06/21/2024 | Date of earliest transaction (acquisition of stock options) |
| 06/21/2024 | Stock options exercisable date |
| 06/20/2034 | Stock options expiration date |
| 06/21/2027 | Date of full vesting of stock options |
| 06/25/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.